Skip to content
Laxxon Medical

Laxxon Medical

News

Press releases, news and publications from Laxxon Medical.

Press releases

2025

2022

  • Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs

    Laxxon Medical Corp., a U.S.-based pharma-technology company pioneering 3D screen printed pharmaceuticals, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent 11,419,824 B2 for the controlled administration of one or more active pharmaceutical ingredients within a drug delivery system via oral dosage forms.

News

2026

  • Laxxon Medical to Participate in the Jefferies Global Healthcare Conference

    Laxxon Medical Corp. (“Laxxon Medical” or the “Company”), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs) technology, today announced that members of its senior management team will hold one-on-one investor meetings at the Jefferies Global Healthcare Conference, taking place November 16–19, 2026, in London, United Kingdom.

2025

2024

2023

2022

Publications

  1. Enke M, Bünger M, Aedtner E, Kastner S, Gruschwitz F, Kühne K, Czernik-Schulz D, Greeley DR, Volc D, Buzachnich-Ladinig A, Schneeberger A. Three-Dimensional Screen Printing Technology Enables Sequential Release of Carbidopa and Levodopa—A New Approach Improving Levodopa Delivery for Treating Parkinson’s Disease. Pharmaceutics. 2025;17(12), 1507. https://doi.org/10.3390/pharmaceutics17121507
  2. Schwarz N, Enke M, Gruschwitz FV, Winkler D, Franzmann S, Jescheck L, Hanf F, Schneeberger A. 3D Screen Printing Offers Unprecedented Anticounterfeiting Strategies for Oral Solid Dosage Forms Feasible for Large Scale Production. Pharmaceutics. 2024;16(3), 368. https://doi.org/10.3390/pharmaceutics16030368
  3. Enke M, Schwarz N, Gruschwitz F, Winkler D, Hanf F, Jescheck L, Seyferth S, Fischer D, Schneeberger A. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles. International Journal of Pharmaceutics. 2023;642, 123101. https://doi.org/10.1016/j.ijpharm.2023.123101
  4. Moldenhauer D, Nguyen DCY, Jescheck L, Hack F, Fischer D, Schneeberger A. 3D screen printing – An innovative technology for large-scale manufacturing of pharmaceutical dosage forms. International Journal of Pharmaceutics. 2021;592, 120096. https://doi.org/10.1016/j.ijpharm.2020.120096
Evidence on the Platform page →

Events

Jefferies Global Healthcare Conference

November 16–19, 2026 · London

J.P. Morgan Healthcare Conference

January 11–14, 2027 · San Francisco

Request a meeting →